⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DRMAW News
Dermata Therapeutics, Inc. Warrant
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
accessnewswire.com
DRMA
DRMAW
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
accessnewswire.com
DRMA
DRMAW
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
accessnewswire.com
DRMA
DRMAW
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments
accessnewswire.com
DRMA
DRMAW